Regen BioPharma Inc logo

Regen BioPharma Inc

OTCPK:RGBP (USA)  
$ 0.30 -0.0347 (-10.36%) 10:08 PM EST
At Loss
Volume:
47.81K
Avg Vol (2M):
19.70K
Trade In:
Volume:
47.81K
At Loss
Avg Vol (2M):
19.70K

Business Description

Description
Regen BioPharma Inc is a US-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.
Name Current Vs Industry Vs History
Cash-To-Debt 0.11
Equity-to-Asset -36.71
Debt-to-Equity -0.13
Debt-to-EBITDA -0.84
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -261.2
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 27.41
9-Day RSI 31.44
14-Day RSI 34.53
6-1 Month Momentum % 8.43
12-1 Month Momentum % -54.08

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.02
Quick Ratio 0.02
Cash Ratio 0.02
Days Sales Outstanding 56.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -48.5
Shareholder Yield % 2.22

Financials (Next Earnings Date:2024-07-25 Est.)

RGBP's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:RGBP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Regen BioPharma Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.236
EPS (TTM) ($) -0.26
Beta 0.96
Volatility % 84.41
14-Day RSI 34.53
14-Day ATR ($) 0.140216
20-Day SMA ($) 0.522959
12-1 Month Momentum % -54.08
52-Week Range ($) 0.25996 - 2.02
Shares Outstanding (Mil) 4.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Regen BioPharma Inc Filings

Filing Date Document Date Form
No Filing Data

Regen BioPharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Regen BioPharma Inc Frequently Asked Questions

What is Regen BioPharma Inc(RGBP)'s stock price today?
The current price of RGBP is $0.30. The 52 week high of RGBP is $2.02 and 52 week low is $0.26.
When is next earnings date of Regen BioPharma Inc(RGBP)?
The next earnings date of Regen BioPharma Inc(RGBP) is 2024-07-25 Est..
Does Regen BioPharma Inc(RGBP) pay dividends? If so, how much?
Regen BioPharma Inc(RGBP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1